Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance

N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438.

Authors

Matteo Zignol¹, Anna S Dean¹, Dennis Falzon¹, Wayne van Gemert¹, Abigail Wright¹, Armand van Deun¹, Françoise Portaels¹, Adalbert Laszlo¹, Marcos A Espinal¹, Ariel Pablos-Méndez¹, Amy Bloom¹, Mohamed A Aziz¹, Karin Weyer¹, Ernesto Jaramillo¹, Paul Nunn¹, Katherine Floyd¹, Mario C Raviglione¹

Affiliation

¹ From the World Health Organization, Geneva (M.Z., A.S.D., D.F., W.G., A.W., K.W., E.J., P.N., K.F., M.C.R.); Institute of Tropical Medicine, Antwerp, Belgium (A.D., F.P.); Laboratory Centre for Disease Control, Ottawa (A.L.); Pan American Health Organization-World Health Organization (M.A.E.) and the U.S. Agency for International Development (A.P.-M., A.B.), Washington, DC; and the World Health Organization, Cairo (M.A.A.).

PMID: 27626523
DOI: 10.1056/NEJMsr1512438

No abstract available

Publication types

Historical Article

MeSH terms

Antitubercular Agents / therapeutic use*
Drug Resistance, Bacterial*
Global Health
History, 20th Century
History, 21st Century
Humans
Mycobacterium tuberculosis / drug effects*
Population Surveillance
Tuberculosis, Multidrug-Resistant / drug therapy
Tuberculosis, Multidrug-Resistant / epidemiology*
Tuberculosis, Multidrug-Resistant / history

Substances

Antitubercular Agents

Grants and funding

001/WHO_/World Health Organization/International